🚀 VC round data is live in beta, check it out!
Amoeba Valuation Multiples
Discover revenue and EBITDA valuation multiples for Amoeba and similar public comparables like Casa Grande, Norcod, New Zealand Rural Land, Northern Technologies and more.
Amoeba Overview
About Amoeba
Amoeba SA is a France-based company engaged in developing, producing, and commercializing a biological biocide for use in the industrial sector. It develops Biomeba, a green biocide that harnesses the biocidal properties of Willaertia magna, which is used to treat cooling towers.
Founded
2010
HQ
Employees
23
Website
Financials (LTM)
EV
$89M
Amoeba Financials
Amoeba reported last 12-month revenue of $2M and negative EBITDA of ($6M).
In the same LTM period, Amoeba generated ($48K) in gross profit, ($6M) in EBITDA losses, and had net loss of ($9M).
Revenue (LTM)
Amoeba P&L
In the most recent fiscal year, Amoeba reported revenue of $346K and EBITDA of ($6M).
Amoeba expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2M | XXX | $346K | XXX | XXX | XXX |
| Gross Profit | ($48K) | XXX | ($3M) | XXX | XXX | XXX |
| Gross Margin | (3%) | XXX | (867%) | XXX | XXX | XXX |
| EBITDA | ($6M) | XXX | ($6M) | XXX | XXX | XXX |
| EBITDA Margin | (364%) | XXX | (1767%) | XXX | XXX | XXX |
| EBIT Margin | (436%) | XXX | (2067%) | XXX | XXX | XXX |
| Net Profit | ($9M) | XXX | ($9M) | XXX | XXX | XXX |
| Net Margin | (555%) | XXX | (2483%) | XXX | XXX | XXX |
| Net Debt | — | — | $9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Amoeba Stock Performance
Amoeba has current market cap of $80M, and enterprise value of $89M.
Market Cap Evolution
Amoeba's stock price is $1.03.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $89M | $80M | -0.5% | XXX | XXX | XXX | $-0.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAmoeba Valuation Multiples
Amoeba trades at 55.6x EV/Revenue multiple, and (15.3x) EV/EBITDA.
EV / Revenue (LTM)
Amoeba Financial Valuation Multiples
As of April 14, 2026, Amoeba has market cap of $80M and EV of $89M.
Equity research analysts estimate Amoeba's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Amoeba has a P/E ratio of (9.0x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $80M | XXX | $80M | XXX | XXX | XXX |
| EV (current) | $89M | XXX | $89M | XXX | XXX | XXX |
| EV/Revenue | 55.6x | XXX | 257.0x | XXX | XXX | XXX |
| EV/EBITDA | (15.3x) | XXX | (14.5x) | XXX | XXX | XXX |
| EV/EBIT | (12.8x) | XXX | (12.4x) | XXX | XXX | XXX |
| EV/Gross Profit | (1843.1x) | XXX | (29.7x) | XXX | XXX | XXX |
| P/E | (9.0x) | XXX | (9.3x) | XXX | XXX | XXX |
| EV/FCF | (8.0x) | XXX | (11.0x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Amoeba Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Amoeba Margins & Growth Rates
Amoeba's revenue in the last 12 month grew by 405%.
Amoeba's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
Amoeba Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 405% | XXX | 1270% | XXX | XXX | XXX |
| EBITDA Margin | (364%) | XXX | (1767%) | XXX | XXX | XXX |
| EBITDA Growth | (37%) | XXX | (17%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 182% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 427% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 666% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 1421% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Amoeba Public Comps
See public comps and valuation multiples for other Agriculture and Bioindustrials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Amoeba | XXX | XXX | XXX | XXX | XXX | XXX |
| Casa Grande | XXX | XXX | XXX | XXX | XXX | XXX |
| Norcod | XXX | XXX | XXX | XXX | XXX | XXX |
| New Zealand Rural Land | XXX | XXX | XXX | XXX | XXX | XXX |
| Northern Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| Baikowski | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Amoeba M&A Activity
Amoeba acquired XXX companies to date.
Last acquisition by Amoeba was on XXXXXXXX, XXXXX. Amoeba acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Amoeba
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAmoeba Investment Activity
Amoeba invested in XXX companies to date.
Amoeba made its latest investment on XXXXXXXX, XXXXX. Amoeba invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Amoeba
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Amoeba
| When was Amoeba founded? | Amoeba was founded in 2010. |
| Where is Amoeba headquartered? | Amoeba is headquartered in France. |
| How many employees does Amoeba have? | As of today, Amoeba has over 23 employees. |
| Is Amoeba publicly listed? | Yes, Amoeba is a public company listed on Euronext Paris. |
| What is the stock symbol of Amoeba? | Amoeba trades under ALMIB ticker. |
| When did Amoeba go public? | Amoeba went public in 2015. |
| Who are competitors of Amoeba? | Amoeba main competitors are Casa Grande, Norcod, New Zealand Rural Land, Northern Technologies. |
| What is the current market cap of Amoeba? | Amoeba's current market cap is $80M. |
| What is the current revenue of Amoeba? | Amoeba's last 12 months revenue is $2M. |
| What is the current revenue growth of Amoeba? | Amoeba revenue growth (NTM/LTM) is 405%. |
| What is the current EV/Revenue multiple of Amoeba? | Current revenue multiple of Amoeba is 55.6x. |
| Is Amoeba profitable? | No, Amoeba is not profitable. |
| What is the current EBITDA of Amoeba? | Amoeba has negative EBITDA and is not profitable. |
| What is Amoeba's EBITDA margin? | Amoeba's last 12 months EBITDA margin is (364%). |
| What is the current EV/EBITDA multiple of Amoeba? | Current EBITDA multiple of Amoeba is (15.3x). |
| What is the current FCF of Amoeba? | Amoeba's last 12 months FCF is ($11M). |
| What is Amoeba's FCF margin? | Amoeba's last 12 months FCF margin is (694%). |
| What is the current EV/FCF multiple of Amoeba? | Current FCF multiple of Amoeba is (8.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.